IL157167A0 - Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus - Google Patents

Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus

Info

Publication number
IL157167A0
IL157167A0 IL15716702A IL15716702A IL157167A0 IL 157167 A0 IL157167 A0 IL 157167A0 IL 15716702 A IL15716702 A IL 15716702A IL 15716702 A IL15716702 A IL 15716702A IL 157167 A0 IL157167 A0 IL 157167A0
Authority
IL
Israel
Prior art keywords
reovirus
sensitization
chemotherapeutic agent
neoplastic cells
agent resistant
Prior art date
Application number
IL15716702A
Other languages
English (en)
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of IL157167A0 publication Critical patent/IL157167A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • A61K35/765Reovirus; Rotavirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12211Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12232Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15716702A 2001-02-20 2002-02-19 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus IL157167A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27036301P 2001-02-20 2001-02-20
PCT/CA2002/000201 WO2002066040A2 (fr) 2001-02-20 2002-02-19 Sensibilisation des cellules neoplasiques resistant aux agents chimiotherapeutiques avec un reovirus

Publications (1)

Publication Number Publication Date
IL157167A0 true IL157167A0 (en) 2004-02-08

Family

ID=23031034

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15716702A IL157167A0 (en) 2001-02-20 2002-02-19 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
IL157167A IL157167A (en) 2001-02-20 2003-07-30 Reovirus medicinal product and antitumor for the treatment or prevention of cancer and commercial packaging containing the reovirus and antitumor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL157167A IL157167A (en) 2001-02-20 2003-07-30 Reovirus medicinal product and antitumor for the treatment or prevention of cancer and commercial packaging containing the reovirus and antitumor

Country Status (16)

Country Link
US (5) US7264798B2 (fr)
EP (2) EP1361884B1 (fr)
JP (3) JP4951194B2 (fr)
AR (1) AR035227A1 (fr)
AT (1) ATE516807T1 (fr)
AU (2) AU2002234453B2 (fr)
BR (1) BR0207691A (fr)
CA (1) CA2437468C (fr)
DK (1) DK1361884T3 (fr)
ES (1) ES2367768T3 (fr)
HK (1) HK1060520A1 (fr)
IL (2) IL157167A0 (fr)
MX (1) MXPA03007486A (fr)
NZ (2) NZ537709A (fr)
WO (1) WO2002066040A2 (fr)
ZA (1) ZA200305875B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6136307A (en) 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
AR035227A1 (es) * 2001-02-20 2004-05-05 Oncolytics Biotech Inc Uso de un agente quimioterapeutico para la manufactura de un medicamento para la sensibilizacion de celulas neoplasicas resistentes a agentes quimioterapeuticos con reovirus
BR0311448A (pt) 2002-05-10 2005-03-15 Oncolytics Biotech Inc Métodos para sensibilizar uma célula neoplástica a radiação, para tratar ou melhorar um tumor em um paciente, e para impedir um tumor de desenvolver resistência à radiação em um paciente
MXPA05011462A (es) * 2003-04-25 2005-12-15 Wellstat Biologics Corp Tratamiento de carcinomas hepatocelulares utilizando virus terapeuticos.
MXPA05013879A (es) 2003-06-18 2006-06-27 Genelux Corp Virus de la vaccinia recombinantes modificados y otros microorganismos, y usos de los mismos.
JP5170741B2 (ja) * 2004-04-27 2013-03-27 ウェルスタット バイオロジクス コーポレイション ウイルスおよびカンプトテシン類を使用する癌の処置
WO2005112966A1 (fr) * 2004-05-21 2005-12-01 Orison Biotechnology Inc. Thérapie combinée extrait végétal plus un réovirus pour tuer les cellules néoplasiques chez un sujet
AU2006270297B2 (en) * 2005-07-14 2013-01-17 Wellstat Biologics Corporation Cancer treatment using viruses, fluoropyrimidines and camptothecins
US10668119B2 (en) 2005-08-01 2020-06-02 Virocure, Inc. Attenuated reovirus
EP1917351A4 (fr) * 2005-08-01 2009-12-16 Univ Technologies Int Réovirus atténué
CA2630833C (fr) * 2005-11-24 2015-01-06 Aicuris Gmbh & Co. Kg Parapoxvirus combines a des agents chimiotherapeutiques cytotoxiques classiques comme biochimiotherapie pour le traitement de cancer
WO2008100292A2 (fr) 2006-10-16 2008-08-21 Genelux Corporation Souches du virus de la vaccine modifié pour une utilisation dans des procédés diagnostiques et thérapeutiques
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US10369171B2 (en) 2007-03-13 2019-08-06 Virocure, Inc. Attenuated reoviruses for selection of cell populations
WO2008150496A2 (fr) * 2007-05-31 2008-12-11 Genelux Corporation Essai de sensibilité à des agents chimiothérapeutiques
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
US20090162288A1 (en) * 2007-07-18 2009-06-25 Nanhai Chen Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods
WO2009052617A1 (fr) * 2007-10-22 2009-04-30 Oncolytics Biotech Inc. Régime de traitement pour des troubles prolifératifs
EP2244714A4 (fr) * 2008-02-08 2012-06-06 Poniard Pharmaceuticals Inc Utilisation de picoplatine et de bévacizumab pour traiter un cancer colorectal
WO2009139921A2 (fr) * 2008-05-16 2009-11-19 Genelux Corporation Microorganismes pour la prévention et le traitement de néoplasmes accompagnant une thérapie cellulaire
WO2009143468A1 (fr) * 2008-05-22 2009-11-26 Uti Limited Partnership Prédisposition par suppresseurs de tumeur de cellules hyperproliférantes à une thérapie virale oncolytique
TW200950777A (en) * 2008-05-27 2009-12-16 Oncolytics Biotech Inc Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
US20110086005A1 (en) * 2008-05-27 2011-04-14 Oncolytics Biotech Inc. Modulating interstitial pressure and oncolytic viral delivery and distribution
AU2013204555A1 (en) * 2012-04-30 2013-11-14 Oncolytics Biotech Inc. Protecting modified viruses from neutralizing antibodies using the reovirus sigma 1 protein
CA3003133C (fr) 2014-10-24 2020-09-15 StemImmune, Incorporated Technique d'immunotherapie combinee pour le traitement du cancer
CN104881181B (zh) * 2015-05-27 2019-07-26 联想(北京)有限公司 显示方法及电子设备
US11655455B2 (en) 2018-11-06 2023-05-23 Calidi Biotherapeutics, Inc. Enhanced systems for cell-mediated oncolytic viral therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0931830B1 (fr) 1993-02-16 2001-03-07 Onyx Pharmaceuticals, Inc. Virus cytopathique pour le traitement et la prophylaxie de la neoplasie
PT1314431E (pt) 1993-04-30 2008-10-24 Wellstat Biologics Corp Composições purificadas de vírus da doença de newcastle
US5776743A (en) * 1994-09-06 1998-07-07 La Jolla Cancer Research Foundation Method of sensitizing tumor cells with adenovirus E1A
US6565831B1 (en) * 1999-02-24 2003-05-20 Oncolytics Biotech Inc. Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
US6136307A (en) * 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
US6110461A (en) 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
EP1905304A3 (fr) 1997-10-09 2008-08-13 Wellstat Biologics Corporation Traitement de tumeurs avec des virus
US6428968B1 (en) * 1999-03-15 2002-08-06 The Trustees Of The University Of Pennsylvania Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject
JP2003514024A (ja) * 1999-11-12 2003-04-15 オンコリティクス バイオテク,インコーポレーテッド 細胞増殖性疾患の治療のためのウイルス
AR035227A1 (es) * 2001-02-20 2004-05-05 Oncolytics Biotech Inc Uso de un agente quimioterapeutico para la manufactura de un medicamento para la sensibilizacion de celulas neoplasicas resistentes a agentes quimioterapeuticos con reovirus
US7163678B2 (en) * 2002-11-07 2007-01-16 Oncolytics Biotech Inc. Reovirus for the treatment of ral-mediated cellular proliferative disorders

Also Published As

Publication number Publication date
JP2008120837A (ja) 2008-05-29
EP1361884A2 (fr) 2003-11-19
US8658158B2 (en) 2014-02-25
WO2002066040A3 (fr) 2003-05-30
US20080031851A1 (en) 2008-02-07
JP2012072192A (ja) 2012-04-12
US20110243890A1 (en) 2011-10-06
AU2002234453B2 (en) 2007-05-17
US7608257B2 (en) 2009-10-27
ES2367768T3 (es) 2011-11-08
CA2437468C (fr) 2007-06-19
IL157167A (en) 2014-05-28
US20130017172A1 (en) 2013-01-17
NZ527399A (en) 2005-09-30
ZA200305875B (en) 2004-07-30
JP2004517966A (ja) 2004-06-17
CA2437468A1 (fr) 2002-08-29
EP1361884B1 (fr) 2011-07-20
MXPA03007486A (es) 2003-12-08
DK1361884T3 (da) 2011-10-03
JP4951194B2 (ja) 2012-06-13
EP2314301A2 (fr) 2011-04-27
BR0207691A (pt) 2006-01-31
ATE516807T1 (de) 2011-08-15
WO2002066040A2 (fr) 2002-08-29
US20100021432A1 (en) 2010-01-28
NZ537709A (en) 2006-11-30
US20020168344A1 (en) 2002-11-14
AU2007207860B2 (en) 2008-10-23
AU2007207860A1 (en) 2007-09-06
HK1060520A1 (en) 2004-08-13
WO2002066040A8 (fr) 2003-03-20
US7264798B2 (en) 2007-09-04
EP2314301A3 (fr) 2011-08-17
AR035227A1 (es) 2004-05-05
US7964187B2 (en) 2011-06-21

Similar Documents

Publication Publication Date Title
HK1060520A1 (en) Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
AU2003275140A8 (en) Theree-dimensional construct for the design and fabrication of physiological fluidic networks
MX2019010879A (es) Tratamiento de cancer.
ATE336215T1 (de) Tampon mit spiralförmigen rillen
HUP0401534A3 (en) Modified factor ix
DE60007051D1 (de) Biegsame Röhre und dessen Herstellung
IL160772A0 (en) Pancreatic smal cells and uses thereof
SG108876A1 (en) Multiple hydroprocessing reactors with intermediate flash zones
AU2002301545A1 (en) Multiple hydroprocessing reactors with intermediate flash zones
GB0127033D0 (en) Stent manufacture
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
DE50011273D1 (de) Gasentladungslampe
DE60030708D1 (de) Beschichtete Hartmetallkörper
AU144209S (en) Pocket lamp
GB0000699D0 (en) Gas discharge lamp
CA93349S (en) Pocket lamp
TW506631U (en) Composing structure of spiral antenna
GB0126000D0 (en) Use of 4ñ Phorbol
TW527019U (en) Improved structure of cubic cell
GB0101943D0 (en) Ultra violet reflector
GB0119757D0 (en) Long-term selective inhibition of cellular and viral genes
TWI319005B (en) Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
TW450340U (en) Water lamp structure with inner and outer tubes
GB0113597D0 (en) Inflatable with memory retention
HU9802984D0 (en) Spiral shaped low-pressure gas discharge lamp